PlainPharmaWatch

CMS Open Payments · Program Year 2024

Qiagen, LLC

Qiagen, LLC reported $1,031,661.90 across General Payments, Research, and Ownership to 881 physicians and teaching hospitals across 894 transactions.

$1.0M
All-tracks total
894
Transactions
881
Recipients
−$444.0K
General Payments vs PY2023

Qiagen, LLC reported $1,031,661.90 across all CMS Open Payments tracks (General + Research + Ownership) to 881 physicians and teaching hospitals in Program Year 2024 - ranking #616 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $659,841.51, averaging $1.2K per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

CMS Sunshine Act warrant

Manufacturer qiagen-llc Qiagen, LLC

$1.0M · #616/1,925 · 0.0% industry · PY2024

  • TOT $1.0M
  • RANK #616
  • SHARE 0.0%
  • TXN 894
  • RCP 881
  • CAT 9
  • GEN $659.8K
  • ΔGEN −$444.0K
  • TOP1 22.8%
  • PY 2024

Nearest volume peer: iotaMotion, Inc. ($1.0M)

Radius Health, Inc.$1.0MiotaMotion, Inc.$1.0MQiagen, LLC (this)$1.0MPENTAX of America, Inc.$1.0MVarex Imaging Corporation$1.0M
All-tracks payment totals near Qiagen, LLC (CMS Open Payments PY2024)

Qiagen, LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

Release-over-release change

General Payments changed from PY2023 to PY2024

Qiagen, LLC's CMS-reported General Payments decreased by $444.0K (−40.2%) from PY2023 to PY2024.

How this year-over-year comparison is scoped

The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.

CMS source labels for this exact identifier: PY2022: QIAGEN, LLCPY2023: QIAGEN, LLCPY2024: QIAGEN, LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$1.1MPY2024$659.8K
PY2023
$1,103,846.70
PY2024
$659,841.51

What the Data Shows for Qiagen, LLC

$1,031,661.90: that is what Qiagen, LLC reported in payments to 881 physicians and teaching hospitals during Program Year 2024, spread across 894 transactions ($1.2K per transaction, $1.2K per recipient). The company sits at rank #616 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

"Consulting Fee" leads the 9-category general-payment breakdown below at $400.3K (60.7% of General Payments, 109 transactions) - see our methodology for how research and ownership payments are reported separately.

General Payment Breakdown by Type

"Consulting Fee" leads Qiagen, LLC's 9-category general-payment breakdown at $400.3K, 60.7% of the reported total.

Qiagen, LLC reports 9 general-payment categories - the top three are Consulting Fee (60.7%), Debt Forgiveness (18.3%), and Compensation for Services Other Than Consulting (16.2%). The remaining 6 categories make up 4.9% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.

Category breadth matters here: Qiagen, LLC files across 9 named CMS general-payment types in Program Year 2024, versus manufacturers that report a single dominant category. The chart and table below enumerate every type with an amount above zero for this company.

How Qiagen, LLC divides its payments

Ranked by total dollars reported per category

1. Consulting Fee$400.3K2. Debt Forgiveness$120.7K3. Compensation for Services…$106.6K4. Royalty or License$13.2K5. Gift$7.5K6. Food and Beverage$6.8K7. Space Rental or Facility …$2.8K8. Long-Term Medical Supply …$1.7K9. Education$290.00
Payment Type Amount Transactions
Consulting Fee $400.3K 109
Debt Forgiveness $120.7K 427
Compensation for Services Other Than Consulting $106.6K 5
Royalty or License $13.2K 5
Gift $7.5K 1
Food and Beverage $6.8K 329
Space Rental or Facility Fees $2.8K 3
Long-Term Medical Supply or Device Loan $1.7K 1
Education $290.00 1

Recipient Concentration in General Payments

The five largest recipient relationships account for $391,952.68 (59.4%) of $659,841.51 in this company's General Payments records across 376 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Qiagen, LLC

The five named recipients with the highest reported General Payments from this company

Ross L Levine$150.4KUniversity of Iowa Hosp & Cl…$107.7KMassachusetts General Hospit…$63.1KRichard Mark White$42.0KMikael Lee Rinne$28.8K
  1. 1

    Ross L Levine

    $150,356.13 across 3 reported transactions

  2. 2

    University of Iowa Hosp & Clinics

    $107,708.27 across 6 reported transactions

  3. 3

    Massachusetts General Hospital

    $63,088.28 across 338 reported transactions

  4. 4

    Richard Mark White

    $42,000.00 across 12 reported transactions

  5. 5

    Mikael Lee Rinne

    $28,800.00 across 11 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Qiagen, LLC's, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Qiagen, LLC.

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Qiagen, LLC.

Showing 6 of 1,924 companies with CMS-reported payment data.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

View saved (companies)
Download Qiagen, LLC's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.